Last reviewed · How we verify
NCT04229862
Effect of Head Elevation on LMA Insertion
NA trial testing Laryngeal mask airway insertion in Laryngeal Masks in 110 participants. Completed in 5 May 2020.
5 April 2020
Quick facts
| Lead sponsor | Asan Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 110 |
| Start date | 14 February 2020 |
| Primary completion | 5 April 2020 |
| Estimated completion | 5 May 2020 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Laryngeal mask airway insertion
Conditions studied
- Laryngeal Masks — all drugs for Laryngeal Masks →
- Urinary Bladder Neoplasms — all drugs for Urinary Bladder Neoplasms →
Sponsor
Asan Medical Center
Who can join
Adults 20 to 79, any sex, with Laryngeal Masks or Urinary Bladder Neoplasms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to compare the first attempt success rate of laryngeal mask airway insertion according to the degree of head elevation.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Head elevation and laryngeal mask airway Supreme insertion: A randomized controlled trial.
Park JY, Yu J, Hong JH, Hwang JH, et al · · 2021 · cited 6× · PMID 33174199 · DOI 10.1111/aas.13742
Verify or expand the search:
- PubMed search for NCT04229862
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Laryngeal Masks
Currently open trials in the same condition.
- NCT06617403 — Pre-operative Characteristics for Prediction of Supraglottic Airway Failure Using Machine Learning (ERICA) · active not recruiting
- NCT03502590 — IGEL Laryngeal Mask Airway Device Effectiveness in Irradiated Necks · NA · recruiting
Other Asan Medical Center trials
Trials by the same sponsor.
- NCT07530393 — Blood Viscosity and Outcomes After Elective Craniotomy · not yet recruiting
- NCT07010497 — A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Be · Phase 2 · recruiting
- NCT07382505 — Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cerv · not yet recruiting
- NCT07489092 — Feasibility of a Digital Rehabilitation Platform in Patients After ICU Discharge · NA · recruiting
- NCT07431762 — Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Hear · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04229862 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Asan Medical Center
- Last refreshed: 29 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04229862.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing